Aggression and psychopharmacological treatments in major psychosis and personality disorders during hospitalisation

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 7, 2011, Pages 1631-1635

  Mauri, M C ^a   Rovera, C ^a   Paletta, S ^a   De Gaspari, I F ^a   Maffini, M ^a   Altamura, A C ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

Aggression; Antidepressants; Antipsychotics; Psychopharmacology

Indexed keywords

AMISULPRIDE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; CLOZAPINE; FLUPHENAZINE; FLUVOXAMINE; GABAPENTIN; HALOPERIDOL; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PAROXETINE; QUETIAPINE; RISPERIDONE; SERTRALINE; VALPROIC ACID; ZIPRASIDONE; ZUCLOPENTHIXOL; ZUCLOPENTHIXOL DECANOATE;

ABNORMAL BEHAVIOR; ADULT; AGE DISTRIBUTION; AGED; AGGRESSION; ALCOHOL ABUSE; ARTICLE; BIPOLAR DISORDER; BRIEF PSYCHIATRIC RATING SCALE; CLINICAL ASSESSMENT; CONTROLLED STUDY; CORRELATIONAL STUDY; DELUSIONAL DISORDER; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MODIFIED OVERT AGGRESSION SCALE; NEUROPSYCHOLOGICAL TEST; PERSONALITY DISORDER; PSYCHOSIS; SCHIZOPHRENIA; SCORING SYSTEM; VIOLENCE;

ADULT; AGED; AGED, 80 AND OVER; AGGRESSION; ANTIPSYCHOTIC AGENTS; FEMALE; HOSPITALIZATION; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MENTAL DISORDERS; MIDDLE AGED; PERSONALITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; VIOLENCE; YOUNG ADULT;

EID: 79961129264     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2011.05.008     Document Type: Article

References (32)

1. American Psychiatry Association Diagnostic and statistical manual of mental disorders (DSM)-IV-TR 1994, APA, Washington.
2. Amoo G., Fatoye F.O. Aggressive behaviour and mental illness: a study of in-patients at Aro Neuropsychiatric Hospital, Abeokuta. Niger J Clin Pract 2010, 13(3):351-355.
3. Arango C., Bernardo M. The effect of quetiapine on aggression and hostility in patients with schizophrenia. Hum Psychopharmacol 2005, 20(4):237-241.
4. Buckley P., Bartell J., Donenwirth K., Lee S., Torigoe F., Schulz S.C. Violence and schizophrenia: clozapine as a specific antiaggressive agent. Bull Am Acad Psychiatry Law 1995, 23(4):607-611.
5. Carrillo M., Ricci L.A., Coppersmith G.A., Melloni R.H. The effect of increased serotoninergic neurotransmission on aggression: a critical meta-analytical review of preclinical studies. Psychopharmacol. 2009, 205:349-368.
6. Cheung P., Schweitzer I., Yastrubetskaya O., Crowley K., Tuckwell V. Studies of aggressive behaviour in schizophrenia: is there a response bias?. Med Sci Law 1997, 37(4):345-348.
7. Clotfelter E.D., O'Hare E.P., McNitt M.M., Carpenter R.E., Summers C.H. Serotonin decreases aggression via 5-HT1A receptors in the fighting fish Betta spendens. Pharmacol Biochem Behav 2007, 87(2):222-231.
8. Colasanti A., Natoli A., Moliterno D., De Gaspari I.F., Mauri M.C. Psychiatric diagnosis and aggression before acute hospitalisation. Eur Psychiatry 2008, 23(6):441-448.
9. Colasanti A., Paletta S., Moliterno D., Mazzocchi A., Mauri M.C., Altamura A.C. Symptom dimensions as predictors of clinical outcome, duration of hospitalization, and aggressive behaviours in acutely hospitalized patients with psychotic exacerbation. Clin Pract Epidemiol Ment Health. 2010, 6:72-78.
10. Davidson R.J., Putnam K.M., Larson C.L. Dysfunction in the neural circuitry of emotion regulation - a possible prelude to violence. Science 2000, 289(5479):591-594.
11. Eichelman B., Hartwig A. The Carolina Nosology of Destructive Behavior (CNDB). J Neuropsychiatry Clin Neurosci 1990, 2(3):288-296.
12. Ferns T., Cork A. Managing alcohol related aggression in the emergency department (Part I). Int Emerg Nurs 2008, 16(1):43-47.
13. Herrera F.M., Velazquez Martinez D.N. Discriminative stimulus properties of amphetamine in a conditioned taste aversion paradigm. Behav Pharmacol 1997, 8(5):458-464.
14. Hodgins S. Mental disorder, intellectual deficiency and crime: evidence from a birth cohort. Arch Gen Psychiatry 1992, 49:476-483.
15. Hyunjoo S., Sung Kil M. Aggressive behaviour model in schizophrenic patients. Psychiatry Res 2009, 167:58-65.
16. Kirsch P., Ronshausen S., Mier D., Gallhofer B. The influence of antipsychotic treatment on brain reward system reactivity in schizophrenia patients. Pharmacopsychiatry 2007, 40(5):196-198.
17. Krakowski M. Violence and serotonin: influence of impulse control, affect regulation, and social functioning. J Neuropsichiatry Clin Neurosci. 2003, 15(3):294-305.
18. Krakowski M.I., Czobor P., Citrome L., Bark N., Cooper T.B. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder. Arch Gen Psychiatry 2006, 63(6):622-629.
19. Lesch K.P., Merschdorf U. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav Sci Law 2000, 18(5):581-604.
20. Lindenmayer J.P., Kanellopoulou I. Schizophrenia with impulsive and aggressive behaviour. Psychiatr Clin North Am 2009, 32(4):855-902.
21. Mercer D., Douglass A.B., Links P.S. Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Pers Disord 2009, 23(2):156-174.
22. Mitrev I.N., Massaldjieva R.I. Suicidal behaviour and aggression in psychiatric inpatients. Folia Med (Plovdiv). 2004, 46(4):22-26.
23. Mizrahi R., Rusian P., Agid O., et al. Adverse subjective experience with antipsychotics and its relationschip to striatal and extrastriatal D2 receptors: a PET study in schizophrenia. Am J Psichiatry. 2007, 164(4):630-637.
24. Overall J., Gorham D. Brief Psychiatric Rating Scale. Psychol Rep. 1962, 10:799-812.
25. Pabis D.J., Stanislay S.W. Pharmacotherapy of aggressive behaviour. Ann Pharmacother 1996, 30(3):278-287.
26. Penzer J.B., Dudas M., Saito E., et al. Lack of effect of stimulant combination with second-generation antipsychotics on weight gain, metabolic changes, prolactin levels, and sedation in youth with clinically relevant aggression or oppositionality. J Child Adolesc Psychopharmacol 2009, 19(5):563-573.
27. Perreault H.A., Semsar K., Godwin J. Fluoxetine treatment decreases territorial aggression in a coral reef fish. Physiol Behav 2003, 79(4-5):719-724.
28. Swanson J.W., Holzer C., Gantu V.K., Jono R.T. Violence and psychiatric disorder in the community: evidence from the epidemiologic catchment area surveys. Hosp Community Psychiatry 1990, 41:761-770.
29. Volavka J., Laska E., Baker S., Meisner M., Czobor P., Krivelevich I. History of violent behaviour and schizophrenia in different cultures. Analyses based on the WHO study on determinants of outcomes of severe mental disorders. Br J Psichiatry. 1997, 171:9-14.
30. Yudofsky S.C., Silver J.M., Jackson W., Endicott J., William D. Overt Aggression Scale for the objective rating of verbal and physical aggression. Am J of Psych. 1986, 143:35-39.
31. Zaghdoudi L., Homri W., Belaid S., Ben Bechir M., Labbene R. Quality of life of patients with schizophrenia treated by conventional and atypical neuroleptics. Tunis Med 2009, 87(9):593-598.
32. Zeller S.L. Review: evidence on the effect of antiepileptics on recurrent aggression inconclusive. Evid Based Mental Health 2010, 13(3):85-86.